Management of BPH then 2000 and now 2016 - From BPH to BPO.

about

Current consensus and controversies on male LUTS/BPH (part one).

P2860

Q55085373-7F1AA943-BD50-475B-B310-24F47FD61099

P2860

Management of BPH then 2000 and now 2016 - From BPH to BPO.

Item

http://www.wikidata.org/entity/Q51776593

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Management of BPH then 2000 and now 2016 - From BPH to BPO.

@en

Management of BPH then 2000 and now 2016 - From BPH to BPO.

@nl

type

Item

label

Management of BPH then 2000 and now 2016 - From BPH to BPO.

@en

Management of BPH then 2000 and now 2016 - From BPH to BPO.

@nl

prefLabel

Management of BPH then 2000 and now 2016 - From BPH to BPO.

@en

Management of BPH then 2000 and now 2016 - From BPH to BPO.

@nl

P1476

Management of BPH then 2000 and now 2016 - From BPH to BPO.

@en

P2093

Johan Braeckman

http://www.w3.org/2001/XMLSchema#string

Louis Denis

http://www.w3.org/2001/XMLSchema#string

P2860

Role for intravesical prostatic protrusion in lower urinary tract symptom: a fluid structural interaction analysis study.

A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction

Alpha-blocker therapy can be withdrawn in the majority of men following initial combination therapy with the dual 5alpha-reductase inhibitor dutasteride.

Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience.

Prostate tissue retrieval after holmium laser enucleation of the prostate; assessment of non-morcellation approaches

Diagnosis and treatment of benign prostate hyperplasia in Asia.

Transurethral vaportrode electrovaporization of the prostate: physical principles, technique, and results.

Decision making in the management of benign prostatic enlargement and the role of transabdominal ultrasound.

Non-steroidal anti-inflammatory drugs for lower urinary tract symptoms in benign prostatic hyperplasia: systematic review and meta-analysis of randomized controlled trials.

The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy.

P304

138-147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1016/J.AJUR.2017.02.002

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29264222

http://www.w3.org/2001/XMLSchema#string

P932

5717990

http://www.w3.org/2001/XMLSchema#string

Management of BPH then 2000 and now 2016 - From BPH to BPO.

about

P2860

P2860

Management of BPH then 2000 and now 2016 - From BPH to BPO.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932